Skip to content
Review Open access

Autophagy at the Crossroads of Protein and RNA Toxicity in Repeat Expansion Cerebellar Ataxias

Aug 2026 · Cells · Vol 15, pp. 1411 · 0 citations · 95 references
Medicine

TL;DR

Evidence supporting autophagy impairment as a convergent pathogenic pathway in repeat expansion cerebellar ataxias is discussed.

Abstract

Repeat expansion cerebellar ataxias comprise a genetically and mechanistically heterogeneous group of neurodegenerative disorders unified by the pathological expansion of short tandem repeats (STRs) beyond a disease-causing threshold. Depending on their genomic localization, these expansions can lead to toxic protein gain-of-function, as in polyglutamine (polyQ) cerebellar ataxias, or to RNA-mediated toxicity and repeat-associated non-AUG (RAN) translation, for which recent evidence supports a major pathogenic role in non-coding spinocerebellar ataxias (SCAs). Despite these distinct upstream mechanisms, disruption of neuronal homeostasis occurs through converging pathogenic processes, including proteostasis impairment, transcriptional dysregulation, and mitochondrial dysfunction, leading to progressive neuronal loss. Importantly, impaired autophagy has been consistently reported across multiple repeat expansion ataxias, including both dominant SCAs and recessive conditions, such as Friedreich’s ataxia, suggesting that impairment of this pathway may represent a shared downstream event in disease progression. Indeed, in polyQ cerebella ataxias, the accumulation of misfolded and aggregation-prone proteins places a substantial burden on cellular quality control systems, particularly the ubiquitin-proteasome system and autophagy. Similarly, in non-coding SCAs, toxic RNA species and RAN-derived peptides might interfere with protein clearance mechanisms and contribute to cellular stress. In this review, we will discuss the evidence supporting autophagy impairment as a convergent pathogenic pathway in repeat expansion cerebellar ataxias.

Read PDF

Similar papers

Review Open access Sep 2026

MicroRNAs in polyglutamine diseases: Mechanistic insights, circulating biomarkers, and emerging microRNA-based therapeutic strategies.

This review synthesizes recent advances in miRNA dysregulation across all nine PolyQ diseases, focusing on studies published since 2019, and highlights therapeutic progress, including the preclinical efficacy of adeno-associated virus (AAV)-delivered artificial miRNAs and emerging exosome-based platforms that target mu...

Yang Liu, Ying Cui, Miao Sun et al. · 0 citations
Open access Sep 2026

Loss of RUBCN causes autophagy overdrive in a neurodevelopmental disorder with age-dependent neurodegeneration

The RUBCN-related disorders are established and expand as a clinically and molecularly distinct subset of autophagy-related diseases and enhances understanding of autophagy-related neurodevelopmental disorders and provides a foundation for future therapeutic investigations.

S. Efthymiou, K. Tabata, H. Dafsari et al. · 0 citations
Review Open access Oct 2026

Disruption of RNA metabolism and its impact on protein homeostasis

Abstract Repeat-associated disorders arise from expansions of nucleotide repeats in coding or non-coding regions, producing RNAs that accumulate and disrupt cellular homeostasis through mechanisms collectively termed RNA repeat toxicity. This process complements proteotoxicity in coding-region expansions and is increas...

Susana M. D. A. Garcia · 0 citations
Open access Sep 2026

Characterization of Ataxia-linked MFN2 Variants Reveals a Lipid Droplet/Mitochondrial Axis Driving Ferroptosis

Pathogenic variants in the mitochondrial protein Mitofusin 2 have long been recognized to cause the peripheral neuropathy Charcot-Marie-Tooth Type 2A (CMT2A). However, a small subset of MFN2 variants also impact the central nervous system and cause cerebellar ataxia. The reason for this discrepancy and the mechanisms u...

M. Zaman, A. Mohan, C. Chute et al. · 0 citations
Open access Sep 2026

Neurodegeneration and inflammation in a novel spinocerebellar ataxia 13 preclinical model

Neuroinflammation is a critical pathological feature underlying neurodegenerative diseases. Spinocerebellar ataxia 13 (SCA13) is a heterogeneous ataxia with several allelic variations of differing phenotypes. All are neurodegenerative and currently without effective treatment. Our prior work identified human KCNC3...

Jun-Xiang Yin, Michael Wu, Jennifer White et al. · 0 citations
Review Open access Oct 2026

Proteostasis (in)action: the role of co-pathologies in neurodegenerative disease

Abstract Clinically distinct neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD) and amyotrophic lateral sclerosis (ALS), share in common progressive neuronal dysfunction and cell death associated with the accumulation of misfolded proteins. Central to these processes are the cellul...

James F. Morley · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.